We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aortech International Plc | LSE:AOR | London | Ordinary Share | GB0033360586 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 126.50 | 123.00 | 130.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
18/5/2018 13:23 | Exactly why TT? | cocker | |
18/5/2018 10:22 | I have a hunch of news next week | turbotrader2 | |
17/5/2018 09:17 | This is one of my favorite stocks, I keep topping up each month, loads of potential and a true stealth stock. I get the impression that the company simply sticks to the minimal trading updates which i would suggest is why there are sudden jumps in share value as news hits all in one go without any prior indication of how well the business is doing. Still very much under valued | 4x4guru | |
16/5/2018 20:35 | #AOR AorTech Good consolidation today above 50 day MA line after yesterdays breakout on volume. Two day close above 50 day MA should be a positive continuation signal. | the stigologist | |
16/5/2018 11:26 | #AOR AorTech share price : 44p shares o/s : 5.6m mkt cap : £2.4m balance sheet cash : $0.5m? (Dec 2017 RNS : $328k as of Nov 2017) annual cashflow : c.$0.2m? (H1 Interims : Net Cash from Op. $172k) high quality cashflow from IPR licensing/royalty business model optionality from potential licensing of breast implant/heart valve biocompatible materials potential for use of company as a RTO/shell vehicle ? "The tax losses within the accounts also makes AOR attractive to a prospective buyer, as with millions to play with this could well prove to tempting to a profit making organisation" "£23M will attract deal makers. @20% that's £4.6M Discount that by 50% TAX LOSS IS WORTH MORE THAN TODAYS MARKET CAP" chart looks like it's breaking out (note last breakout above 50 day MA in November 2017 preceded big December 2017 150%+ move) Limited shares in issue, very tightly held | the stigologist | |
16/5/2018 10:57 | Nice trade | turbotrader2 | |
16/5/2018 09:51 | Wonder when the news will drop? | turbotrader2 | |
15/5/2018 22:44 | Note the last breakout above the 50 day MA happened just weeks before the major news driven rise of December | the stigologist | |
15/5/2018 19:16 | In all fairness to stiggy there was a lot of info on that twitter thread that would be too much effort to post here | mikeh30 | |
15/5/2018 18:31 | Posting a tweet written by himself. Great work Stig | cocker | |
15/5/2018 12:28 | i think 'Strategic Review' may well have been code for 'we are going to sell up to highest bidder' i'd expect at least 100p+ on takeout and significant in-roads into the 500p+ value of last major placing | the stigologist | |
15/5/2018 12:24 | Added more | turbotrader2 | |
15/5/2018 12:08 | Agreed Stig. Given the market-leading status of Elast-Eon/EcSil, it's a wonder someone like Biomerics hasn't used its petty cash to make an offer for the company or its IP, lock, stock and both barrels. They could then put some serious backing into the heart valve development, maybe? | bones | |
15/5/2018 12:04 | yes agree bought another 2.5k shares | joeblogg2 | |
15/5/2018 12:02 | Still astonished this is valued at such a piddling amount. There are shells with little in the way of assets valued higher than this. The cashflow, balance sheet cash, value of listing, tax shield valuation, potential from licensing/royalties all call for a much higher valuation than that currently afforded this stock. The chart is getting close to a major breakout in my opinion and should be launchpad for considerable move higher given the very limited shares in issue and the very limited free float | the stigologist | |
15/5/2018 10:23 | Agreed - Catch 22, small cap and AIM can deter folks. | semper vigilans | |
15/5/2018 10:19 | Only £2m cap. Ridiculous. | mikeh30 | |
14/5/2018 16:02 | I'd expect it to be over $500k now | the stigologist | |
14/5/2018 15:37 | """"The working capital position also improved with cash increasing, as anticipated, from $114,000 at 31 March 2017 to $286,000 at 30 September 2017 (30 September 2016: $216,000).The recent trading results should indicate to shareholders that the business is on a more stable footing and the risk of failure diminished. The cash position improved during the six months to 30 September 2017 and at the end of November 2017 had further increased to $328,000.We anticipate that the net cash position should improve further."""" | mikeh30 | |
12/5/2018 07:23 | Great posts All, The wait for some great news continues. Best of All | bbr391 | |
10/5/2018 13:59 | I am coming around to possibility of AOR being bought out or used as an RTO vehicle As others have noted previously "The tax losses within the accounts also makes AOR attractive to a prospective buyer, as with millions to play with this could well prove to tempting to a profit making organisation" "£23M will attract deal makers. @20% that's £4.6M Discount that by 50% TAX LOSS IS WORTH MORE THAN TODAYS MARKET CAP" | the stigologist |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions